1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
AI for Health Equity, Analytics, and Diagnostics (AHEAD) Center (seed funding) is sponsored by New York State (Governor Kathy Hochul and SUNY Upstate Medical). This seed funding supports the establishment of the AI for Health Equity, Analytics, and Diagnostics (AHEAD) Center at SUNY Upstate Medical, as part of a broader New York State initiative to advance AI for the public good.
Get alerted about grants like this
Get emailed when new opportunities from “New York State (Governor Kathy Hochul and SUNY Upstate Medical)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Upstate Medical University is one of eight SUNY schools to receive funding to start work on creating centers or other campus elements related to artificial intelligence (AI) and how it will impact society. Upstate will receive $200,000 to help create the AI for Health Equity, Analytics, and Diagnostics (AHEAD) Center for advancing AI research and its application in healthcare. Gov. Hochul announced the funding last week.
Other SUNY schools receiving funding for AI efforts include University at Albany, Binghamton University, University at Buffalo, SUNY Downstate, SUNY College of Environmental Science and Forestry, SUNY Polytechnic Institute and Stony Brook University.
The AHEAD center will leverage AI to advance precision medicine, predictive analytics, diagnostic tools, and biomedical research while addressing potential disparities in healthcare delivery. The AHEAD Center’s mission aligns with Upstate’s broader commitment to improving the health of the communities it serves through education, research, and patient care.
The objectives of the AHEAD Center are designed to integrate AI into healthcare in a responsible, equitable, and innovative manner.
These objectives include: —developing clinically useful AI algorithms to enhance patient care and improve the experience of healthcare providers, students, and staff; —driving innovation in AI by designing novel, transdisciplinary AI architectures to address pressing clinical and research challenges; —educating the next generation by providing AI training to medical, nursing, and graduate students, as well as residents and interns; —ensuring equity and ethical AI by focusing on making AI applications equitable, inclusive, and accessible in healthcare; —community engagement by educating the public about the role of AI in advancing medical research, education, and clinical care; —optimizing AI for healthcare technologies to include enhancing technologies that support clinical care, research, and education.
The AHEAD Center will be interdisciplinary, drawing on expertise from Upstate’s colleges of medicine, nursing, health professions, and graduate studies. Faculty from Syracuse University’s departments of humanities, ethics, and computer science will also contribute to the center’s work. This broad collaboration is designed to harness expertise across healthcare, engineering, social sciences and computing.
In addition to advancing AI research, the AHEAD Center will develop a curriculum to equip students and faculty with the knowledge and skills to apply AI in healthcare. The curriculum will emphasize real-world applications, ethical AI, responsible AI use. The AHEAD Center will play a key role in advancing Upstate’s mission to foster innovation in education, research, and patient care.
By leveraging AI to improve healthcare outcomes and address disparities, the center will help prepare students to be the next generation of leaders in AI and healthcare.
According to the current listing, eligibility includes: SUNY Upstate Medical is establishing this center as part of the state-funded initiative. Confirm the full requirements in the official notice before applying.
AI for Health Equity, Analytics, and Diagnostics (AHEAD) Center (seed funding) is funded by New York State (Governor Kathy Hochul and SUNY Upstate Medical). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
DARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleThe BARK program funds dual-use medical products for warfighters and military working dogs — tourniquets, sensors, drug delivery, and CBRN countermeasures. Proposals close June 3, 2026.
Read article